Edarbi and Edarbyclor for hypertensionTakeda Canada is introducing a new angiotensin II blocker (ARB) for the treatment of hypertension. DIVERSIONS: Dr. Lifestyle's Diary - April 9 Issue, 2013 Crohn’s and Colitis Foundation of Canada and AbbVie to award seven scholarships to empower youth with IBD Nominations now being accepted for second annual scholarship program CLINICAL PEARLS: Decongestants hasten nosebleed relief Alleged quack MD's arrest shows why doctor rating sites hardly foolproof Fake doctor had positive reviews on RateMDs Tell your patients that doing their taxes leads to better health Your patients need to know that taking advantage of tax credits can go a long way to making things easier for low-income Canadians, both in health and finances Bystolic: new beta-blocker for hypertension Forest Laboratories will soon launch a new once-daily beta-blocker for the treatment of mild to moderate essential hypertension. The big picture: Activism in Alberta New budget a "major stress" for PEI pharmacies Province goes ahead with nationally-agreed 18 percent price for top six generics. Remember Richard Speck's nurse victims, not him First Previous 1718 1719 1720 1721 1722 Next Last
